Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It also provides Strensiq (asfotase alfa), a targeted enzyme...
Biotechnology,Pharmaceuticals,Healthcare,Science and Engineering,Biopharmaceutical,Health Care,Complement Inhibition,Medical,Metabolic Disorders,Neurology,Rare Diseases,Research and Development,Transplant,Haematology,Nephrology